Company profile

Persyst Development

Medical Imaging & Radiology

Company profile

About Persyst Development

Persyst Development operates at the intersection of neuroscience and computer science as the worldwide leader in EEG (electroencephalography) software. The company provides comprehensive Computer Assisted Review of EEG (C.A.R.E) solutions that enable accurate, efficient, and rapid review of EEG data for both high-volume institutions and community clinics. Their flagship product, Persyst 15, offers the most advanced seizure detection capabilities available, with clinical validation showing non-inferiority to human expert reviewers. The platform includes sophisticated spike detection, comprehensive EEG trending tools, real-time artifact reduction, and multi-patient monitoring capabilities. Persyst is uniquely positioned as the only EEG trending and detection software integrated, sold, and supported by every major EEG manufacturer including Micromed, Natus, Nihon Kohden, Cadwell, and Compumedics. The company has pioneered mobile EEG monitoring with Persyst Mobile, the first FDA-cleared EEG monitoring and review application for mobile devices. Persyst serves neurologists, epileptologists, and healthcare institutions worldwide, with their technology recognized as the standard of care at leading epilepsy centers. The company maintains a strong commitment to research and scientific validation, publishing findings in peer-reviewed journals and collaborating with clinical partners to advance the field of quantitative EEG for neurodiagnostics.

Company description Persyst Development official website

Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceLinkedIn X
Work at Persyst Development?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • epilepsy
  • neurological disorders requiring EEG monitoring
  • seizures

Who it serves

  • Community Clinics
  • Epilepsy Centers
  • Health Systems
  • Hospitals
  • Research Institutions

Deployment & integration

Cloud Saas · Embedded · Hybrid · On Premise deployment with recorded integration context.

Recorded integration context: Cadwell, Compumedics, Micromed, Natus, Nihon Kohden.

Geographic context

MarketsEU · UK · USA · worldwide
Company sourceOfficial website

Company milestones

Platform expansion

Launch of Persyst 15 described as 'Our Biggest Version Ever', FDA clearance of Persyst Mobile as first mobile EEG monitoring application, 2025 ANA-Persyst Professional Development Award announced at 150th Annual Meeting of American Neurological Association

Partnerships

Recorded partners

  • American Neurological Association
  • Cadwell
  • Compumedics
  • Micromed
  • Natus
  • Nihon Kohden

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Artifact Reduction

Real-time selective reduction of eye, muscle and electrode artifacts

Software · EmbeddedCompany source

Continuous Monitoring and Clinical Review

Comprehensive patient monitoring from wherever you are

Software · HybridCompany source

Multi-Patient Monitor

Monitor multiple patients simultaneously with Persyst technology

Software · On PremiseCompany source

Persyst 15

EEG Review and Analysis Software for Computer Assisted Review of EEG (C.A.R.E)

Software · On PremiseCompany source

Persyst ESI

EEG Electrical Source Imaging for advanced neurological analysis

Software · On PremiseCompany source

Persyst Mobile

First FDA-cleared EEG monitoring and review application for mobile devices

Software · Cloud SaaSCompany source

Persyst Mobile Cloud

Cloud-based EEG access and collaboration platform

Platform · Cloud SaaSCompany source

Seizure Detection

Most advanced seizure detector available with non-inferior performance to human experts

Software · EmbeddedCompany source

Spike Detection

Spike detection shown to be non-inferior to skilled human reviewers

Software · EmbeddedCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

Non-inferior performance to human experts

Seizure detection algorithm performance validated in peer-reviewed study

Non-inferior to skilled human reviewers

Spike detection accuracy

Accurate, efficient and rapid review

EEG data analysis and monitoring

Top US Epilepsy Centers

EEG monitoring and analysis as standard of care

Used by top epilepsy centers as ranked by US News and NAEC

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Michael Jaramillo

Unknown

06 · Company updates

Updates from Persyst Development

Recent articles published on Persyst Development's official website.

No Company updates are currently listed.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Medical Imaging & Radiology

Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon